Big Pharma Investor Panel: From Molecule to Market: Navigating Patentability, Costs, & Investment Challenges in Psychosis Drug Development
Time: 3:00 pm
day: Day Two
Details:
- Key hurdles in securing patents for psychotic medications and innovations
- Strategies for extending patent life (e.g., formulation changes, new indications)
- Cost factors unique to psychotic medication, including long trial durations and patient recruitment challenges
- Understanding the high-risk nature of psychiatric drug development and its impact on investor interest
- Key investment drivers and barriers to funding psychosis treatment research
- The role of public and private sectors in bridging funding gaps for mental health innovation
